Allogeneic Stem Cell Transplantation: Clinical Trials

6 trials for Allogeneic Stem Cell Transplantation, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 terminated, 1 completed, 1 not yet recruiting, 1 withdrawn. 6 Phase 1, 3 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 16Terminated 3, Completed 1, Not yet recruiting 1, Withdrawn 1
Phase 23Not yet recruiting 1, Terminated 1, Withdrawn 1

Follow Allogeneic Stem Cell Transplantation: new trials by email Literature Review of Allogeneic Stem Cell Transplantation trials Research Report on Allogeneic Stem Cell Transplantation

Trials (filtered) newest first · largest first

All 6 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Trial of an Investigational Drug After Rejecting the Relapse of an Allogeneic Transplant
CARTemis-1 - Multiple Myeloma, Allogeneic Stem Cell Transplantation
Phase 1 / Phase 2Not yet recruitingFundación Pública Andaluza para la gestión de la Investigación en Sevilla252024-12-302024-05-14
A Study of Siremadlin Alone and in Combination With Donor Lymphocyte Infusion in Acute Myeloid Leukemia Post-allogeneic Stem Cell Transplant
Siremadlin - Acute Myeloid Leukemia, Allogeneic Stem Cell Transplantation
Phase 1 / Phase 2TerminatedNovartis Pharmaceuticals82023-02-232025-05-16
Autologous Cytomegalovirus (CMV) Specific CD8+ T Cells as Treatment for CMV Reactivation
Lymphopheresis, CMV specific lymphocyte infusion, Peripheral blood for CMV DNA PCR - CMV Reactivation, Allogeneic Stem Cell Transplantation
Phase 1 / Phase 2WithdrawnImperial College London2011-04-012015-06-08
Safety and Efficacy of ProHema Modulated Umbilical Cord Blood Units in Subjects With Hematologic Malignancies.
Fludarabine, Melphalan, Antithymocyte Globulin - Hematologic Malignancies, Allogeneic Stem Cell Transplantation
Phase 1CompletedFate Therapeutics122011-01-012013-10-08
Recombinant Human Growth Hormone (RH-GH) For Accelerating Immune Reconstitution Post Unrelated Cord Blood Transplant
Genotropin (Recombinant Human Growth Hormone) - Allogeneic Stem Cell Transplantation
Phase 1TerminatedMitchell Horwitz, MD142008-09-012014-03-20
CMV pp65 Specific T Cell Adoptive Immunotherapy in Allogeneic Stem Cell Transplantation for Malignant Disease
CMV pp65 Specific T Cells - Allogeneic Stem Cell Transplantation
Phase 1TerminatedH. Kim Lyerly22005-08-012012-11-12

Narrower conditions

Hematologic Neoplasms (2)  ·  Leukemia (1)  ·  Leukemia, Myeloid, Acute (1)  ·  Multiple Myeloma (1)

Broader conditions

Hematologic Diseases (4)  ·  Hemic and Lymphatic Diseases (4)  ·  Neoplasms (4)  ·  Neoplasms by Histologic Type (3)  ·  Neoplasms by Site (2)  ·  Blood Protein Disorders (1)  ·  Cardiovascular Diseases (1)  ·  Hemorrhagic Disorders (1)  ·  Hemostatic Disorders (1)  ·  Immune System Diseases (1)  ·  Immunoproliferative Disorders (1)  ·  Leukemia (1)  ·  Leukemia, Myeloid (1)  ·  Lymphoproliferative Disorders (1)  ·  Neoplasms, Plasma Cell (1)

Interventions

Antilymphocyte Serum (1)  ·  Blood Chemical Analysis (1)  ·  Growth Hormone (1)  ·  Human Growth Hormone (1)  ·  Leukapheresis (1)  ·  Melphalan (1)  ·  Sirolimus (1)  ·  Tacrolimus (1)  ·  fludarabine (1)  ·  siremadlin (1)

Sponsors

Fate Therapeutics (1)  ·  Fundación Pública Andaluza para la gestión de la Investigación en Sevilla (1)  ·  H. Kim Lyerly (1)  ·  Imperial College London (1)  ·  Mitchell Horwitz, MD (1)  ·  Novartis Pharmaceuticals (1)

Countries

United States (3)  ·  Spain (2)  ·  Germany (1)  ·  Italy (1)  ·  United Kingdom (1)

Top investigators

Corey Cutler, MD, MPH, FRCP(C) (1)  ·  H. Kim Lyerly, M.D. (1)  ·  Jose-Antonio Perez-Simon, MD-PhD (1)  ·  Katy Rezvani, MD (1)  ·  Michael A Morse, M.D. (1)  ·  Mitchell Horwitz, MD (1)

Results publications

PMID 23996087